BPI has established a modern manufacturing facility for the production of oral cytotoxic solid dosages, to meet the growing need for anti-cancer products.

Fully segregated manufacturing suites are strictly designed following International guidelines to protect the personnel and environment and to produce efficient lifesaving drugs.
  • High-level Containment Compliant Manufacturing Suites 
  • Isolator Technology 
  • Advanced and Dedicated Air Handling System and HEPA Filtration 
  • State -of-the-art Closed Transfer System Equipment  
  • Specialized Quality Control Laboratories